Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleic acid encapsulation and intracellular delivery refers to a class of technologies designed to protect nucleic acids (DNA, RNA) from enzymatic degradation in the bloodstream, enhance their uptake into cells, and promote their release into the cytoplasm or nucleus for therapeutic effect. These strategies use non-viral systems such as lipid nanoparticles, polymers, or inorganic materials to encapsulate and transport the genetic material through biological barriers. These delivery systems are essential for the efficacy of gene therapies and nucleic acid-based drugs, addressing key challenges such as poor cellular uptake, rapid clearance, low stability, and the need for endosomal escape. However, they represent delivery strategies rather than discrete molecular therapeutic targets, and thus should not be categorized as canonical molecular entities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleic acid encapsulation and intracellular delivery.